Fine particulate matter pollution linked to respiratory illness in infants and increased hospital costs

Perry Sheffield1, Angkana Roy, Kendrew Wong

  • 1Mount Sinai School of Medicine, in New York City, USA. perry.sheffield@mssm.edu

Insights

Fine particulate air pollution increases healthcare costs for infant bronchiolitis. Reducing pollution could save millions in child healthcare expenses, highlighting the need for stricter air quality standards.

Area of Science:

  • Environmental Health
  • Pediatric Health
  • Public Health

Background:

  • Limited research exists on the connection between air pollution and childhood infectious respiratory illnesses.
  • Fine particulate matter (PM2.5) is a significant air pollutant with potential health impacts.

Purpose of the Study:

  • To investigate the relationship between fine particulate air pollution exposure and healthcare costs associated with bronchiolitis in children.
  • To estimate potential healthcare cost savings from reducing fine particulate matter levels.

Main Methods:

  • Utilized national hospitalization data and air pollutant data.
  • Analyzed the correlation between infant lifetime exposure to fine particulate matter and healthcare costs for bronchiolitis treatment.

Main Results:

  • Increased average exposure to fine particulate matter correlated with higher healthcare costs for infants diagnosed with bronchiolitis.
  • Reducing fine particulate matter levels by 7% below the current annual standard could save an estimated $15 million annually in US urban areas.

Conclusions:

  • Findings underscore the importance of continued efforts to reduce air pollutant levels.
  • Further research is recommended to assess if current fine particulate matter standards adequately protect children's health.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...